Evidence map›Paper›PMID 36213130›Full record

ArticleFrontiers in molecular biosciences2022

A comprehensive next generation sequencing tissue assay for Asian-prevalent cancers-Analytical validation and performance evaluation with clinical samples.

Cedric Chuan-Young Ng, Sandy Lim, Abner Herbert Lim, Nur Diyana Md Nasir, Jingxian Zhang, Vikneswari Rajasegaran, Jing Yi Lee, Jessica Sook Ting Kok, Aye Aye Thike, Johnathan Xiande Lim and 7 more

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Cedric Chuan-Young NgCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Sandy LimDiagnostics Development Hub (DxD Hub), A National Platform Hosted by ASTAR, Singapore, Singapore.
Abner Herbert LimCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Nur Diyana Md NasirDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Jingxian ZhangDiagnostics Development Hub (DxD Hub), A National Platform Hosted by ASTAR, Singapore, Singapore.
Vikneswari RajasegaranCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Jing Yi LeeCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Jessica Sook Ting KokCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Aye Aye ThikeDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Johnathan Xiande LimDivision of Pathology, Singapore General Hospital, Singapore, Singapore.
Ruifen WengDiagnostics Development Hub (DxD Hub), A National Platform Hosted by ASTAR, Singapore, Singapore.
Sidney YeeDiagnostics Development Hub (DxD Hub), A National Platform Hosted by ASTAR, Singapore, Singapore.
Yukti ChoudhuryLucence Diagnostics Pte Ltd, Singapore, Singapore.
Jason Yongsheng ChanCancer Discovery Hub, National Cancer Centre Singapore, Singapore, Singapore.
Puay Hoon TanDepartment of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
Min-Han TanLucence Diagnostics Pte Ltd, Singapore, Singapore.
Bin Tean TehLaboratory of Cancer Epigenome, National Cancer Centre Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asian cancersgenetic alterationhybrid capturemolecular diagnosticsnext-generation sequence (NGS)tissue assay

Identifiers

PMID36213130
PMCPMC9532579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.